Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 99

1.

Mycobacterium talmoniae sp. nov., a slowly growing mycobacterium isolated from human respiratory samples.

Davidson RM, DeGroote MA, Marola JL, Buss S, Jones V, McNeil MR, Freifeld AG, Elaine Epperson L, Hasan NA, Jackson M, Iwen PC, Salfinger M, Strong M.

Int J Syst Evol Microbiol. 2017 Aug;67(8):2640-2645. doi: 10.1099/ijsem.0.001998. Epub 2017 Aug 15.

PMID:
28809146
2.

Efficacy of β-Lactam/β-Lactamase Inhibitor Combinations for the Treatment of Bloodstream Infection Due to Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae in Hematological Patients with Neutropenia.

Gudiol C, Royo-Cebrecos C, Abdala E, Akova M, Álvarez R, Maestro-de la Calle G, Cano A, Cervera C, Clemente WT, Martín-Dávila P, Freifeld A, Gómez L, Gottlieb T, Gurguí M, Herrera F, Manzur A, Maschmeyer G, Meije Y, Montejo M, Peghin M, Rodríguez-Baño J, Ruiz-Camps I, Sukiennik TC, Tebe C, Carratalà J; BICAR Study Group.

Antimicrob Agents Chemother. 2017 Jul 25;61(8). pii: e00164-17. doi: 10.1128/AAC.00164-17. Print 2017 Aug.

PMID:
28584145
3.

Clinical efficacy of β-lactam/β-lactamase inhibitor combinations for the treatment of bloodstream infection due to extended-spectrum β-lactamase-producing Enterobacteriaceae in haematological patients with neutropaenia: a study protocol for a retrospective observational study (BICAR).

Gudiol C, Royo-Cebrecos C, Tebe C, Abdala E, Akova M, Álvarez R, Maestro-de la Calle G, Cano A, Cervera C, Clemente WT, Martín-Dávila P, Freifeld A, Gómez L, Gottlieb T, Gurguí M, Herrera F, Manzur A, Maschmeyer G, Meije Y, Montejo M, Peghin M, Rodríguez-Baño J, Ruiz-Camps I, Sukiennik TC, Carratalà J; BICAR study group.

BMJ Open. 2017 Jan 23;7(1):e013268. doi: 10.1136/bmjopen-2016-013268.

4.

Clostridium difficile-Associated Diarrhea in the Oncology Patient.

Neemann K, Freifeld A.

J Oncol Pract. 2017 Jan;13(1):25-30. doi: 10.1200/JOP.2016.018614. Review.

PMID:
28084880
5.

Nocardia arthritidis as a cause of disseminated nocardiosis in a patient with chronic lymphocytic leukemia.

Roberts AL, Davidson RM, Freifeld AG, Iwen PC.

IDCases. 2016 Sep 28;6:68-71. eCollection 2016.

6.

The epidemiology and outcomes of invasive Candida infections among organ transplant recipients in the United States: results of the Transplant-Associated Infection Surveillance Network (TRANSNET).

Andes DR, Safdar N, Baddley JW, Alexander B, Brumble L, Freifeld A, Hadley S, Herwaldt L, Kauffman C, Lyon GM, Morrison V, Patterson T, Perl T, Walker R, Hess T, Chiller T, Pappas PG; TRANSNET Investigators.

Transpl Infect Dis. 2016 Dec;18(6):921-931. doi: 10.1111/tid.12613. Epub 2016 Nov 14.

PMID:
27643395
7.

When to Use Prophylactic Antibiotics in Neutropenic Patients.

Zimmer A, Freifeld A.

Oncology (Williston Park). 2016 Sep 15;30(9):838-40, 846. No abstract available.

PMID:
27633416
8.

Prevention and Treatment of Cancer-Related Infections, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology.

Baden LR, Swaminathan S, Angarone M, Blouin G, Camins BC, Casper C, Cooper B, Dubberke ER, Engemann AM, Freifeld AG, Greene JN, Ito JI, Kaul DR, Lustberg ME, Montoya JG, Rolston K, Satyanarayana G, Segal B, Seo SK, Shoham S, Taplitz R, Topal J, Wilson JW, Hoffmann KG, Smith C.

J Natl Compr Canc Netw. 2016 Jul;14(7):882-913.

PMID:
27407129
9.

Blood Cultures for Persistent Fever in Neutropenic Pediatric Patients Are of Low Diagnostic Yield.

Neemann K, Yonts AB, Qiu F, Simonsen K, Lowas S, Freifeld A.

J Pediatric Infect Dis Soc. 2016 Jun;5(2):218-21. doi: 10.1093/jpids/piu145. Epub 2015 Feb 4.

PMID:
27199474
10.

The emerging problem of bacterial resistance in cancer patients; proceedings of a workshop held by MASCC "Neutropenia, Infection and Myelosuppression" Study Group during the MASCC annual meeting held in Berlin on 27-29 June 2013.

Rapoport B, Klastersky J, Raftopoulos H, Freifeld A, Aoun M, Zinner SH, Rolston KV.

Support Care Cancer. 2016 Jul;24(7):2819-26. doi: 10.1007/s00520-016-3183-5. Epub 2016 Apr 20. No abstract available.

PMID:
27098065
11.
12.

Current practices for treatment of respiratory syncytial virus and other non-influenza respiratory viruses in high-risk patient populations: a survey of institutions in the Midwestern Respiratory Virus Collaborative.

Beaird OE, Freifeld A, Ison MG, Lawrence SJ, Theodoropoulos N, Clark NM, Razonable RR, Alangaden G, Miller R, Smith J, Young JA, Hawkinson D, Pursell K, Kaul DR.

Transpl Infect Dis. 2016 Apr;18(2):210-5. doi: 10.1111/tid.12510. Epub 2016 Mar 29.

PMID:
26923867
13.

Respiratory Syncytial Virus in Hematopoietic Stem Cell Transplantation and Solid-Organ Transplantation.

Neemann K, Freifeld A.

Curr Infect Dis Rep. 2015 Jul;17(7):490. doi: 10.1007/s11908-015-0490-9.

PMID:
26068871
14.

Histoplasmosis complicating tumor necrosis factor-α blocker therapy: a retrospective analysis of 98 cases.

Vergidis P, Avery RK, Wheat LJ, Dotson JL, Assi MA, Antoun SA, Hamoud KA, Burdette SD, Freifeld AG, McKinsey DS, Money ME, Myint T, Andes DR, Hoey CA, Kaul DA, Dickter JK, Liebers DE, Miller RA, Muth WE, Prakash V, Steiner FT, Walker RC, Hage CA.

Clin Infect Dis. 2015 Aug 1;61(3):409-17. doi: 10.1093/cid/civ299. Epub 2015 Apr 13.

15.

Treatment and outcomes of invasive fusariosis: review of 65 cases from the PATH Alliance(®) registry.

Horn DL, Freifeld AG, Schuster MG, Azie NE, Franks B, Kauffman CA.

Mycoses. 2014 Nov;57(11):652-8. doi: 10.1111/myc.12212. Epub 2014 Jun 18.

16.

Viridans group streptococci in febrile neutropenic cancer patients: what should we fear?

Freifeld AG, Razonable RR.

Clin Infect Dis. 2014 Jul 15;59(2):231-3. doi: 10.1093/cid/ciu264. Epub 2014 Apr 21. No abstract available.

PMID:
24755859
17.

Reduction in false-positive Aspergillus serum galactomannan enzyme immunoassay results associated with use of piperacillin-tazobactam in the United States.

Vergidis P, Razonable RR, Wheat LJ, Estes L, Caliendo AM, Baden LR, Wingard JR, Baddley J, Assi M, Norris S, Chandrasekar P, Shields R, Nguyen H, Freifeld A, Kohler R, Kleiman M, Walsh TJ, Hage CA.

J Clin Microbiol. 2014 Jun;52(6):2199-201. doi: 10.1128/JCM.00285-14. Epub 2014 Apr 9.

18.

Endemic fungal infections in solid organ and hematopoietic cell transplant recipients enrolled in the Transplant-Associated Infection Surveillance Network (TRANSNET).

Kauffman CA, Freifeld AG, Andes DR, Baddley JW, Herwaldt L, Walker RC, Alexander BD, Anaissie EJ, Benedict K, Ito JI, Knapp KM, Lyon GM, Marr KA, Morrison VA, Park BJ, Patterson TF, Schuster MG, Chiller TM, Pappas PG.

Transpl Infect Dis. 2014 Apr;16(2):213-24. doi: 10.1111/tid.12186. Epub 2014 Mar 4.

19.

MSG-01: A randomized, double-blind, placebo-controlled trial of caspofungin prophylaxis followed by preemptive therapy for invasive candidiasis in high-risk adults in the critical care setting.

Ostrosky-Zeichner L, Shoham S, Vazquez J, Reboli A, Betts R, Barron MA, Schuster M, Judson MA, Revankar SG, Caeiro JP, Mangino JE, Mushatt D, Bedimo R, Freifeld A, Nguyen MH, Kauffman CA, Dismukes WE, Westfall AO, Deerman JB, Wood C, Sobel JD, Pappas PG.

Clin Infect Dis. 2014 May;58(9):1219-26. doi: 10.1093/cid/ciu074. Epub 2014 Feb 18.

PMID:
24550378
20.

CMX001 to prevent cytomegalovirus disease in hematopoietic-cell transplantation.

Marty FM, Winston DJ, Rowley SD, Vance E, Papanicolaou GA, Mullane KM, Brundage TM, Robertson AT, Godkin S, Momméja-Marin H, Boeckh M; CMX001-201 Clinical Study Group.

N Engl J Med. 2013 Sep 26;369(13):1227-36. doi: 10.1056/NEJMoa1303688.

Supplemental Content

Loading ...
Support Center